FINAL SAFETY ANALYSIS OF 1,793 CML PATIENTS FROM ENACT (EXPANDING NILOTINIB ACCESS IN CLINICAL TRIALS) STUDY IN ADULT PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Nicolini, FE; Alimena, G; Al-Ali, HK; Turkina, AT; Shen, Z; Jootar, S; Smith, G; De Souza, C; Wang, J; Berton, M; Szczudlo, T; Rizzieri, DA

Published Date

  • June 1, 2009

Published In

Volume / Issue

  • 94 /

Start / End Page

  • 255 - 256

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0390-6078

Language

  • English

Conference Location

  • Berlin, GERMANY